​AstraZeneca to make multimillion-pound investment in UK site

Britain’s second-biggest drugmaker to improve Macclesfield facilities but is still not committing to manufacturing expansion AstraZeneca, Britain’s second-largest drugmaker, is to announce further investment in its Macclesfield site in northern England, in a boost for Britain’s £60bn life sciences industry. The move, worth tens of millions of pounds, is expected to be announced this week when the government launches its industrial strategy for the sector in Birmingham on